🦾 Titanium Heart: 100 Days to Transplant Breakthrough

These sources detail a groundbreaking medical event where an Australian man survived for 100 days using a fully artificial titanium heart, the BiVACOR Total Artificial Heart, before successfully receiving a heart transplant. Developed by an Australian bioengineer, the BiVACOR device utilises magnetic levitation and a single moving part, representing a significant advancement in artificial heart technology designed as a bridge to transplant. This successful trial at St Vincent's Hospital Sydney, a world first for discharge with such a device, offers considerable hope for the millions globally suffering from heart failure and awaiting transplants. Experts believe this achievement, supported by Australian government investment in artificial heart research, signals a potential future where artificial hearts could become a more viable and even long-term treatment option. The case provides crucial insights for future trials and the ongoing development of this life-saving technology.